The cell expansion market comprises cell isolation, cryopreservation, culture and storage of cells across various clinical therapeutics including cancer and regenerative medicine. Cell expansion techniques enable scientific researchers to multiply cell populations in controlled laboratory environments, allowing high-yield production of cells for various therapeutic applications. The demand for expanded cell populations is driven by the development of cell therapies in areas such as cancer immunotherapies, vaccine development and regenerative medicine where large quantities of viable cells are needed. The cell expansion process is essential for maintaining and growing populations of healthy, functional cells for administration in patients or for further molecular or biological analysis.
The Global cell expansion market is estimated to be valued at US$ 16,035.5 Mn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the cell expansion market are Becton, Dickinson and Company, Sartorius AG, Merck KGaA, Corning, Inc., Eppendorf SE, Lonza Group AG, PromoCell, Danaher, Thermo Fisher Scientific, HiMedia Laboratories, STEMCELL Technologies Inc., REPROCELL Inc., Bio-Techne, Valiant Co., Ltd., Miltenyi Biotec, Biologos, Cyagen US Inc.
The key opportunities in the market include the growing adoption of regenerative medicine therapies and increasing clinical trials for novel cancer immunotherapies. With advancements in cell-based research, the demand for improved cell expansion systems is on the rise.
Globally, North America dominated the cell expansion market in 2021 owing to presence of major market players and flourishing biotechnology industry in the region. However, Asia Pacific is expected to witness highest growth during the forecast period supported by increasing healthcare investments, growing biopharmaceutical industry and rising prevalence of chronic diseases.
Market drivers
The major market driver is the increasing demand for novel cancer therapies such as CAR T-cell therapies. Cell expansion plays a vital role in generating adequate cell populations required for clinical administration of these innovative immunotherapies. Other drivers include rising stem cell research activities, growing biologics market and surge in funding for regenerative medicine research.
PEST Analysis
Political: Cell expansion technologies are gaining importance in research and development for new therapies. Governments are supporting R&D in this sector through funding and regulations.
Economic: The cell expansion market is driven by increasing investments in stem cell research and regenerative medicine. Cost of cell therapies is decreasing with technological advancements, improving affordability.
Social: As awareness of cell therapies grows, social acceptance of techniques like stem cell research is increasing. Customers prefer therapies derived from cell culturing and tissue engineering over traditional alternatives.
Technological: Automation and closed and continuous systems are making cell expansion solutions more effective and scalable. Adherent and suspension culture techniques enable controlled growth of various cell types for applications in drug development and therapeutics.
North America region holds the major share of the global cell expansion market. The increasing prevalence of chronic diseases and high healthcare spending in the US and Canada support the growth of the cell therapy and biotechnology sectors in this region.
The Asia Pacific region is expected to grow at the fastest rate during the forecast period. Rising government funding for stem cell research programs and expanding biopharmaceutical industry in countries like China, India, and South Korea are driving the cell expansion market in Asia Pacific. Growing healthcare infrastructure and patient population offers lucrative opportunities.
